SEC Filing Details
Document Details
Form
Filing Date
March 17, 2017
Document Date
March 17, 2017
Form Description
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Filing Group
Registration Statements
Company
Mersana Therapeutics
Issuer
Mersana Therapeutics, Inc.